VERV NASDAQ
Verve Therapeutics, Inc.
1W: +1.6%
1M: -0.4%
3M: +103.5%
1Y: +55.0%
3Y: -65.5%
$11.13
Last traded 2025-07-24 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$60M
Revenue
+271.4% YoY
$-181M
Net Income
+8.0% YoY
$-147M
Free Cash Flow
+1.9% YoY
100.0%
Gross Margin
-111.1%
Op. Margin
-94.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-34.3%
ROA-26.9%
ROIC-365.4%
Valuation
P/E-4.7
P/B1.9
EV/EBITDA0.1
Leverage
Debt/Equity0.14
Current Ratio9.84
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z-0.16
Beneish M0.80